BOSTON, May 5, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that its Board of Directors has approved an effective time at...
Read More Details
Finally We wish PressBee provided you with enough information of ( TransCode Therapeutics Announces Effective Date for 1-for-28 Reverse Stock Split )
Also on site :
- USPS slammed as ‘failed system’ after 1,000s of letters & packages found abandoned in mail centers following huge delays
- 'Explosive-laden vehicle hit convoy': 16 Pakistan troops killed in suicide attack
- ‘Like a wastepaper basket’: Life as a child refugee fleeing home